J Korean Med Sci.  2021 Apr;36(16):e111. 10.3346/jkms.2021.36.e111.

Impact of the COVID-19 Outbreak on Emergency Care Utilization in Patients with Acute Myocardial Infarction: a Nationwide Population-based Study

• Sung HK
• Paik JH
• Lee YJ
• Kang S

• KMID: 2515088
• DOI: http://doi.org/10.3346/jkms.2021.36.e111

Abstract

Background
The coronavirus disease 2019 (COVID-19) pandemic has impacted various aspects of daily living and has influenced the life of every individual in a unique way. Acute myocardial infarction (AMI) is associated with high morbidity and mortality; thus, timely treatment is crucial to prevent poor prognosis. Therefore, an immediate emergency department (ED) visit is required; however, no domestic studies have reported the effect of COVID-19 on ED visits by patients with AMI. Therefore, this study aimed to assess the changes in the pattern of ED visits by patients with AMI by comparing visits during the COVID-19 outbreak period to those during two control periods.
Methods
This nationwide, retrospective study used registry data of the National Emergency Department Information System. The ‘outbreak period’ was defined as the period between February 21, 2020 and April 1, 2020, while the ‘control period’ was defined as the same time period in the preceding two years (2018 and 2019). The primary outcome of our study was the number of patients admitted to the ED owing to AMI during the outbreak and control periods. Secondary outcomes were time from symptom onset to ED visit, length of ED stay, and 30-day mortality following admission.
Results
During the outbreak period, 401,378 patients visited the ED; this number was lower than that during the control periods (2018: 577,548; 2019: 598,514). The number of patients with AMI visiting the ED was lower during the outbreak period (2,221) than during 2018 (2,437) and 2019 (2,591).
Conclusion
The COVID-19 pandemic has caused a reduction in ED visits by patients with AMI. We assume that this could likely be caused by misinterpretation of AMI symptoms as symptoms of respiratory infection, fear of contracting severe acute respiratory syndrome coronavirus 2, and restrictions in accessing emergency medical care owing to overburdened healthcare facilities. This study sheds light on the fact that healthcare and emergency medical staff members must work towards eliminating hurdles due to this pandemic for patients to receive timely emergency care, which in turn will help curb the growing burden of mortality.

Keyword

COVID-19; Emergency Care; Myocardial Infarction

Figure

• 

  Fig. 1 Trend of daily COVID-19 confirmed patients, AMI patients visiting ED in outbreak, control period.AMI = acute myocardial infarction, ED = emergency department, COVID-19 = coronavirus disease 2019.

Reference

1. World Health Organization. Coronavirus disease (COVID-19) situation reports. Updated 2020. Accessed December 15, 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.

2. Korea Centers for Disease control and Prevention. Coronavirus disease-19 main website. Updated 2020. Accessed December 15, 2020. http://ncov.mohw.go.kr/en/.

3. Heiber M, Lou WY. Effect of the SARS outbreak on visits to a community hospital emergency department. CJEM. 2006; 8(5):323–328. PMID: 17338843.

4. Chen WK, Cheng YC, Chung YT, Lin CC. The impact of the SARS outbreak on an urban emergency department in Taiwan. Med Care. 2005; 43(2):168–172. PMID: 15655430.

5. Paek SH, Kim DK, Lee JH, Kwak YH. The impact of Middle East respiratory syndrome outbreak on trends in emergency department utilization patterns. J Korean Med Sci. 2017; 32(10):1576–1580. PMID: 28875599.

6. Lee SY, Khang YH, Lim HK. Impact of the 2015 Middle East respiratory syndrome outbreak on emergency care utilization and mortality in South Korea. Yonsei Med J. 2019; 60(8):796–803. PMID: 31347336.

7. Jeong H, Jeong S, Oh J, Woo SH, So BH, Wee JH, et al. Impact of Middle East respiratory syndrome outbreak on the use of emergency medical resources in febrile patients. Clin Exp Emerg Med. 2017; 4(2):94–101. PMID: 28717779.

8. Boserup B, McKenney M, Elkbuli A. The impact of the COVID-19 pandemic on emergency department visits and patient safety in the United States. Am J Emerg Med. 2020; 38(9):1732–1736. PMID: 32738468.

9. Ham CH, Moon HJ, Kim JH, Park YK, Lee TH, Kwon WK. Coronavirus disease (COVID-19) outbreak and its impact on spinal daily practice : preliminary report from a single (regional) University Hospital in Republic of Korea. J Korean Neurosurg Soc. 2020; 63(4):407–414. PMID: 32455517.

10. Kim Y, Ahn E, Lee S, Lim DH, Kim A, Lee SG, et al. Changing patterns of medical visits and factors associated with no-show in patients with rheumatoid arthritis during COVID-19 pandemic. J Korean Med Sci. 2020; 35(48):e423. PMID: 33316859.

11. Ryu JH, Min MK, Lee DS, Yeom SR, Lee SH, Wang IJ, et al. Changes in relative importance of the 5-level triage system, Korean triage and acuity scale, for the disposition of emergency patients induced by forced reduction in its level number: a multi-center registry-based retrospective cohort study. J Korean Med Sci. 2019; 34(14):e114. PMID: 30977315.

12. Cha WC, Ahn KO, Shin SD, Park JH, Cho JS. Emergency department crowding disparity: a nationwide cross-sectional study. J Korean Med Sci. 2016; 31(8):1331–1336. PMID: 27478347.

13. Ahn S. Final report of health insurance big data-based monitoring of cardiovascular and cerebrovascular disease. Cheongju, Korea: Korea Centers for Disease Control and Prevention;2017.

14. Kim D. A study on the comparison of operational definitions of diseases based on health insurance claims data. Goyang, Korea: National Health Insurance Institute Ilsan Hospital;2017.

15. Trabattoni D, Montorsi P, Merlino L. Late STEMI and NSTEMI patients' emergency calling in COVID-19 outbreak. Can J Cardiol. 2020; 36(7):1161.e7–1161.e8.

16. Metzler B, Siostrzonek P, Binder RK, Bauer A, Reinstadler SJ. Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage. Eur Heart J. 2020; 41(19):1852–1853. PMID: 32297932.

17. De Rosa S, Spaccarotella C, Basso C, Calabrò MP, Curcio A, Filardi PP, et al. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J. 2020; 41(22):2083–2088. PMID: 32412631.

18. Tam CF, Cheung KS, Lam S, Wong A, Yung A, Sze M, et al. Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment–elevation myocardial infarction care in Hong Kong, China. Circ Cardiovasc Qual Outcomes. 2020; 13(4):e006631. PMID: 32182131.

19. Solomon MD, McNulty EJ, Rana JS, Leong TK, Lee C, Sung SH, et al. The COVID-19 pandemic and the incidence of acute myocardial infarction. N Engl J Med. 2020; 383(7):691–693. PMID: 32427432.

20. Li YH, Huang WC, Hwang JJ. Taiwan Society of Cardiology. No reduction of ST-segment elevation myocardial infarction admission in Taiwan during coronavirus pandemic. Am J Cardiol. 2020; 131:133–134. PMID: 32713656.

21. Mafham MM, Spata E, Goldacre R, Gair D, Curnow P, Bray M, et al. COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England. Lancet. 2020; 396(10248):381–389. PMID: 32679111.

22. Niccoli G, Luescher TF, Crea F. Decreased myocardial infarction admissions during COVID times: what can we learn? Cardiovasc Res. 2020; 116(10):e126–e128. PMID: 32463078.